Abstract
OBJECTIVES—To assess the clinical features of biopsy proven and negative biopsy temporal arteritis at the time of diagnosis and during a three year follow up. METHODS—Newly diagnosed cases of giant cell arteritis were included in a prospective, multicentre study. Initial clinical and biological features, season of diagnosis, and cardiovascular events occurring during the follow up were recorded. Biopsy proven and negative biopsy cases were compared. RESULTS—Two hundred and seven biopsy proven, and 85 negative biopsy cases were included from 1991 to 1997. Fifty eight per cent of the biopsy proven cases, compared with 39.29% of the negative biopsy cases, were diagnosed during the autumn or winter (p = 0.003). Visual problems (31.5%, v 19.1%, p = 0.031), blindness (9.7% v 2.38%, p = 0.033), jaw claudication (40.8%, v 28.243%, p = 0.044), and temporal artery palpation abnormalities (61.3% v 29.5%, p = 7.10-7) were more frequent in the biopsy proven than in the negative biopsy group. Less specific symptoms, such as headache (82.5% v 92.9%, p = 0.021), or associated polymyalgia rheumatica (40.1% v 65.9%, p = 9 × 10-5) were more prevalent in the negative biopsy cases. Biological markers of inflammation were significantly more increased in the biopsy proven group. All cases of blindness occurring after treatment belonged to the biopsy proven group. CONCLUSION—Biopsy proven cases seem to be more severe than biopsy negative cases at the time of diagnosis and during follow up. Seasonal difference at diagnosis may suggest a different aetiological pattern.
Full Text
The Full Text of this article is available as a PDF (119.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barrier J., Bignon J. D., Soulillou J. P., Grolleau J. Increased prevalence of HLA-DR4 in giant-cell arteritis. N Engl J Med. 1981 Jul 9;305(2):104–105. doi: 10.1056/NEJM198107093050216. [DOI] [PubMed] [Google Scholar]
- Barrier J., Pion P., Massari R., Peltier P., Rojouan J., Grolleau J. Y. Approche épidémiologique de la maladie de Horton dans le département de Loire-Atlantique. 110 cas en 10 ans (1970-1979). Rev Med Interne. 1982 Mar;3(1):13–20. doi: 10.1016/s0248-8663(82)80003-9. [DOI] [PubMed] [Google Scholar]
- Boesen P., Sørensen S. F. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985. Arthritis Rheum. 1987 Mar;30(3):294–299. doi: 10.1002/art.1780300308. [DOI] [PubMed] [Google Scholar]
- Chmelewski W. L., McKnight K. M., Agudelo C. A., Wise C. M. Presenting features and outcomes in patients undergoing temporal artery biopsy. A review of 98 patients. Arch Intern Med. 1992 Aug;152(8):1690–1695. [PubMed] [Google Scholar]
- Delecoeuillerie G., Joly P., Cohen de Lara A., Paolaggi J. B. Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis. 1988 Sep;47(9):733–739. doi: 10.1136/ard.47.9.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Egge K., Midtbo A., Westby R. Arteritis temporalis. Acta Ophthalmol (Copenh) 1966;44(1):49–56. doi: 10.1111/j.1755-3768.1966.tb06430.x. [DOI] [PubMed] [Google Scholar]
- Elling P., Olsson A. T., Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol. 1996 Jan;23(1):112–119. [PubMed] [Google Scholar]
- Evans J. M., O'Fallon W. M., Hunder G. G. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 1995 Apr 1;122(7):502–507. doi: 10.7326/0003-4819-122-7-199504010-00004. [DOI] [PubMed] [Google Scholar]
- Friedman G., Friedman B., Benbassat J. Epidemiology of temporal arteritis in Israel. Isr J Med Sci. 1982 Feb;18(2):241–244. [PubMed] [Google Scholar]
- Gabriel S. E., O'Fallon W. M., Achkar A. A., Lie J. T., Hunder G. G. The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis. J Rheumatol. 1995 Jan;22(1):93–96. [PubMed] [Google Scholar]
- Gonzalez E. B., Varner W. T., Lisse J. R., Daniels J. C., Hokanson J. A. Giant-cell arteritis in the southern United States. An 11-year retrospective study from the Texas Gulf Coast. Arch Intern Med. 1989 Jul;149(7):1561–1565. [PubMed] [Google Scholar]
- Hauser W. A., Ferguson R. H., Holley K. E., Kurland L. T. Temporal arteritis in Rochester, Minnesota, 1951 to 1967. Mayo Clin Proc. 1971 Sep;46(9):597–602. [PubMed] [Google Scholar]
- Hayreh S. S., Podhajsky P. A., Raman R., Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997 Mar;123(3):285–296. doi: 10.1016/s0002-9394(14)70123-0. [DOI] [PubMed] [Google Scholar]
- Hunder G. G., Bloch D. A., Michel B. A., Stevens M. B., Arend W. P., Calabrese L. H., Edworthy S. M., Fauci A. S., Leavitt R. Y., Lie J. T. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990 Aug;33(8):1122–1128. doi: 10.1002/art.1780330810. [DOI] [PubMed] [Google Scholar]
- Huston K. A., Hunder G. G., Lie J. T., Kennedy R. H., Elveback L. R. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978 Feb;88(2):162–167. doi: 10.7326/0003-4819-88-2-162. [DOI] [PubMed] [Google Scholar]
- Kyle V., Cawston T. E., Hazleman B. L. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis. 1989 Aug;48(8):667–671. doi: 10.1136/ard.48.8.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liozon E., Venot J., Liozon F., Vidal E., Weinbreck P., Bordessoule D., Loustaud V. Protéines de l'inflammation dans la maladie de Horton. Etude prospective sur 25 malades. Ann Med Interne (Paris) 1990;141(4):319–324. [PubMed] [Google Scholar]
- Machado E. B., Michet C. J., Ballard D. J., Hunder G. G., Beard C. M., Chu C. P., O'Fallon W. M. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum. 1988 Jun;31(6):745–749. doi: 10.1002/art.1780310607. [DOI] [PubMed] [Google Scholar]
- Manciet G., Dartigues J. F., Decamps A., Barberger-Gateau P., Letenneur L., Latapie M. J., Latapie J. L. The PAQUID survey and correlates of subclinical hypothyroidism in elderly community residents in the southwest of France. Age Ageing. 1995 May;24(3):235–241. doi: 10.1093/ageing/24.3.235. [DOI] [PubMed] [Google Scholar]
- Matteson E. L., Gold K. N., Bloch D. A., Hunder G. G. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med. 1996 Feb;100(2):193–196. doi: 10.1016/s0002-9343(97)89458-2. [DOI] [PubMed] [Google Scholar]
- McDonnell P. J., Moore G. W., Miller N. R., Hutchins G. M., Green W. R. Temporal arteritis. A clinicopathologic study. Ophthalmology. 1986 Apr;93(4):518–530. doi: 10.1016/s0161-6420(86)33706-0. [DOI] [PubMed] [Google Scholar]
- Nordborg E., Bengtsson B. A. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ. 1989 Aug 26;299(6698):549–550. doi: 10.1136/bmj.299.6698.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PAULLEY J. W., HUGHES J. P. Giant-cell arteritis, or arteritis of the aged. Br Med J. 1960 Nov 26;2(5212):1562–1567. doi: 10.1136/bmj.2.5212.1562. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rich S., O'Neill G., Dalmasso A. P., Nerl C., Barbosa J. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes. Diabetes. 1985 May;34(5):504–509. doi: 10.2337/diab.34.5.504. [DOI] [PubMed] [Google Scholar]
- Rodriguez-Valverde V., Sarabia J. M., González-Gay M. A., Figueroa M., Armona J., Blanco R., Fernández-Sueiro J. L., Martínez-Taboada V. M. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Am J Med. 1997 Apr;102(4):331–336. doi: 10.1016/s0002-9343(97)00117-4. [DOI] [PubMed] [Google Scholar]
- Roth A. M., Milsow L., Keltner J. L. The ultimate diagnoses of patients undergoing temporal artery biopsies. Arch Ophthalmol. 1984 Jun;102(6):901–903. doi: 10.1001/archopht.1984.01040030721028. [DOI] [PubMed] [Google Scholar]
- Rubinstein P., Walker M., Ginsberg-Fellner F. Excess of DR3/4 in type I diabetes. What does it portend? Diabetes. 1986 Sep;35(9):985–989. doi: 10.2337/diab.35.9.985. [DOI] [PubMed] [Google Scholar]
- Russo M. G., Waxman J., Abdoh A. A., Serebro L. H. Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism? Arthritis Rheum. 1995 Mar;38(3):374–380. doi: 10.1002/art.1780380312. [DOI] [PubMed] [Google Scholar]
- Salvarani C., Gabriel S. E., O'Fallon W. M., Hunder G. G. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med. 1995 Aug 1;123(3):192–194. doi: 10.7326/0003-4819-123-3-199508010-00006. [DOI] [PubMed] [Google Scholar]
- Salvarani C., Macchioni P. L., Tartoni P. L., Rossi F., Baricchi R., Castri C., Chiaravalloti F., Portioli I. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol. 1987 Jul-Sep;5(3):205–215. [PubMed] [Google Scholar]
- Steven M. M. Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands. Ann Rheum Dis. 1992 Feb;51(2):186–194. doi: 10.1136/ard.51.2.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stuart R. A. Temporary artery biopsy in suspected temporal arteritis: a five year survey. N Z Med J. 1989 Aug 23;102(874):431–433. [PubMed] [Google Scholar]
